Follow Us
https://www.thebody.com/category/tuberculosis-hiv
Physical Health Issues

Tuberculosis and HIV

The Latest

Promo Image

Tuberculosis

What Is TB? TB and HIV: A Bad Pair How Is TB Diagnosed? How Is TB Treated? Medication Problems The Bottom Line

What Is TB?

Tuberculosis (TB) is an infection caused by bacteria. TB usually affects the lungs, but sometimes can affect othe...

Promo Image
Nepal

Nepal: Campaign to Curb TB Infection Among HIV Infected Launched

The government of Nepal recently began a national campaign to prevent persons with HIV infection from contracting TB by distributing isoniazid, an anti-tuberculosis drug, to HIV-infected persons. The program began at the Western Regional Hospital, in...

Promo Image

Tuberculosis and HIV: Background Information

Tuberculosis (TB) is caused by bacteria called Mycobacterium tuberculosis complex and usually affects the lungs. However, among people co-infected with TB and HIV, parts of the body outside the lungs are often affected; this is called extra-pulmonary...

Promo Image

HIV and TB

Fast Facts

Worldwide, TB is the leading cause of death among persons with HIV infection. It is estimated that about 4.2% of Americans, with or without HIV infection, are infected with TB bacteria. In 2005, of the TB patients reported to be co-in...

Promo Image

Barriers to Implementation of Isoniazid Preventive Therapy in HIV Clinics: A Qualitative Study

Though isoniazid preventive therapy (IPT) has been shown to reduce TB incidence among people with HIV, and is recommended in an HIV care program in Gauteng province, its implementation there is low, the study authors noted. Based on in-depth intervie...

Promo Image

Inflammatory Disease Drugs Could Hold TB Treatment Key

Research by American and Canadian scientists suggests how the mechanism behind the anti-inflammatory drugs used to treat diseases such as rheumatoid arthritis might be important in the treatment of TB.

The research in Nature Immunology describes how...

Promo Image

Experimental TB Vaccine For HIV-Positive People Enters Phase II Clinical Trials

Biopharmaceutical company Crucell and the Aeras Global Tuberculosis Vaccine Foundation announced the start of "Phase II clinical trial of a tuberculosis-vaccine candidate targeted at adults infected with HIV," MarketWatch reports. Trials will test th...

Promo Image

An Algorithm for Tuberculosis Screening and Diagnosis in People With HIV

Tuberculosis is a leading cause of death among adults with HIV. In some countries, up to 50 percent of these patients die during TB treatment, usually within two months of the TB diagnosis. Delayed diagnosis is probably a significant contributor to h...

Promo Image

Combination ART, TB Treatment Slash Co-Infected Patient Mortality Rates, Study Finds

The initiation of antiretroviral therapy (ART) during tuberculosis (TB) therapy "significantly improves" treatment-naive, HIV-postive patient survival, a New England Journal of Medicine study finds (Karim et al., 2/25). Combined therapy in the clinic...

Promo Image
News

Tools for TB Advocacy

TAG Launches TB Advocacy Toolkit

TAG has launched the first module of the TB Activist Toolkit. This first module, TB Basics, provides activists with fundamental information about tuberculosis that can strengthen advocacy and scientific literacy arou...